Nanjing Hicin Pharmaceutical Co Ltd (300584) — Capital Reinvestment Ratio

Latest as of June 2025: 0.54x

Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Capital Reinvestment Ratio of 0.54x as of June 2025, meaning it reinvests 1% of its operating cash flow (CN¥22.48 Million) in capital expenditures (CN¥12.11 Million). See 300584 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.54x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥22.48 Million
CNY

Capital Expenditures

CN¥12.11 Million
CNY

Data as of

Jun 2025
Most recent filing

Nanjing Hicin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2012–2025)

This chart tracks Nanjing Hicin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check Nanjing Hicin Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)

Year-by-year Capital Reinvestment Ratio for Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. For live market cap and broader valuation context, see Nanjing Hicin Pharmaceutical Co Ltd market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.80x CN¥78.09 Million CN¥62.64 Million ▼ -38.3%
2024 1.30x CN¥59.96 Million CN¥77.94 Million ▼ -84.2%
2023 8.24x CN¥23.93 Million CN¥197.22 Million ▲ +423.2%
2021 1.58x CN¥59.94 Million CN¥94.41 Million ▼ -3.8%
2020 1.64x CN¥73.39 Million CN¥120.10 Million ▲ +267.1%
2019 0.45x CN¥97.28 Million CN¥43.36 Million ▼ -55.1%
2018 0.99x CN¥77.21 Million CN¥76.67 Million ▼ -30.5%
2017 1.43x CN¥46.56 Million CN¥66.52 Million ▲ +18.2%
2016 1.21x CN¥37.74 Million CN¥45.63 Million ▲ +127.6%
2015 0.53x CN¥53.90 Million CN¥28.63 Million ▼ -55.6%
2014 1.20x CN¥24.29 Million CN¥29.07 Million ▲ +29.9%
2013 0.92x CN¥45.16 Million CN¥41.61 Million ▼ -47.5%
2012 1.75x CN¥38.77 Million CN¥68.03 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow